178 related articles for article (PubMed ID: 17179983)
1. Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival.
Kang MK; Kim RH; Kim SJ; Yip FK; Shin KH; Dimri GP; Christensen R; Han T; Park NH
Br J Cancer; 2007 Jan; 96(1):126-33. PubMed ID: 17179983
[TBL] [Abstract][Full Text] [Related]
2. Bmi-1 extends the life span of normal human oral keratinocytes by inhibiting the TGF-beta signaling.
Kim RH; Lieberman MB; Lee R; Shin KH; Mehrazarin S; Oh JE; Park NH; Kang MK
Exp Cell Res; 2010 Oct; 316(16):2600-8. PubMed ID: 20630502
[TBL] [Abstract][Full Text] [Related]
3. Efficient immortalization of primary human cells by p16INK4a-specific short hairpin RNA or Bmi-1, combined with introduction of hTERT.
Haga K; Ohno S; Yugawa T; Narisawa-Saito M; Fujita M; Sakamoto M; Galloway DA; Kiyono T
Cancer Sci; 2007 Feb; 98(2):147-54. PubMed ID: 17233832
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of BMI-1 correlates with drug resistance in B-cell lymphoma cells through the stabilization of survivin expression.
Bhattacharyya J; Mihara K; Ohtsubo M; Yasunaga S; Takei Y; Yanagihara K; Sakai A; Hoshi M; Takihara Y; Kimura A
Cancer Sci; 2012 Jan; 103(1):34-41. PubMed ID: 21999765
[TBL] [Abstract][Full Text] [Related]
5. Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation.
Lukacs RU; Memarzadeh S; Wu H; Witte ON
Cell Stem Cell; 2010 Dec; 7(6):682-93. PubMed ID: 21112563
[TBL] [Abstract][Full Text] [Related]
6. Effect of siRNA-mediated silencing of Bmi-1 gene expression on HeLa cells.
Jiang Y; Su B; Meng X; Liu C; Liu B; Liu D; Fan Y; Yang H
Cancer Sci; 2010 Feb; 101(2):379-86. PubMed ID: 19930157
[TBL] [Abstract][Full Text] [Related]
7. The translational challenges of precision oncology.
Pich O; Bailey C; Watkins TBK; Zaccaria S; Jamal-Hanjani M; Swanton C
Cancer Cell; 2022 May; 40(5):458-478. PubMed ID: 35487215
[TBL] [Abstract][Full Text] [Related]
8. Single-cell and spatial dissection of precancerous lesions underlying the initiation process of oral squamous cell carcinoma.
Sun L; Kang X; Wang C; Wang R; Yang G; Jiang W; Wu Q; Wang Y; Wu Y; Gao J; Chen L; Zhang J; Tian Z; Zhu G; Sun S
Cell Discov; 2023 Mar; 9(1):28. PubMed ID: 36914617
[TBL] [Abstract][Full Text] [Related]
9. TDO2+ myofibroblasts mediate immune suppression in malignant transformation of squamous cell carcinoma.
Hu S; Lu H; Xie W; Wang D; Shan Z; Xing X; Wang XM; Fang J; Dong W; Dai W; Guo J; Zhang Y; Wen S; Guo XY; Chen Q; Bai F; Wang Z
J Clin Invest; 2022 Oct; 132(19):. PubMed ID: 35972800
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesions.
Gutkind JS; Molinolo AA; Wu X; Wang Z; Nachmanson D; Harismendy O; Alexandrov LB; Wuertz BR; Ondrey FG; Laronde D; Rock LD; Rosin M; Coffey C; Butler VD; Bengtson L; Hsu CH; Bauman JE; Hewitt SM; Cohen EE; Chow HS; Lippman SM; Szabo E
JCI Insight; 2021 Sep; 6(17):. PubMed ID: 34255745
[TBL] [Abstract][Full Text] [Related]
11. Cell-type deconvolution analysis identifies cancer-associated myofibroblast component as a poor prognostic factor in multiple cancer types.
Li B; Pei G; Yao J; Ding Q; Jia P; Zhao Z
Oncogene; 2021 Jul; 40(28):4686-4694. PubMed ID: 34140640
[TBL] [Abstract][Full Text] [Related]
12. Human oral mucosa cell atlas reveals a stromal-neutrophil axis regulating tissue immunity.
Williams DW; Greenwell-Wild T; Brenchley L; Dutzan N; Overmiller A; Sawaya AP; Webb S; Martin D; ; Hajishengallis G; Divaris K; Morasso M; Haniffa M; Moutsopoulos NM
Cell; 2021 Jul; 184(15):4090-4104.e15. PubMed ID: 34129837
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial.
Gurizzan C; Lorini L; Paderno A; Tomasoni M; Zigliani G; Bozzola A; Ardighieri L; Battocchio S; Bignotti E; Ravaggi A; Romani C; De Cecco L; Serafini MS; Miceli R; Bardellini E; Majorana A; Piazza C; Bossi P
BMC Cancer; 2021 May; 21(1):561. PubMed ID: 34001010
[TBL] [Abstract][Full Text] [Related]
14. Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer.
Hornburg M; Desbois M; Lu S; Guan Y; Lo AA; Kaufman S; Elrod A; Lotstein A; DesRochers TM; Munoz-Rodriguez JL; Wang X; Giltnane J; Mayba O; Turley SJ; Bourgon R; Daemen A; Wang Y
Cancer Cell; 2021 Jul; 39(7):928-944.e6. PubMed ID: 33961783
[TBL] [Abstract][Full Text] [Related]
15. Malignant transformation of oral leukoplakia: Systematic review and meta-analysis of the last 5 years.
Aguirre-Urizar JM; Lafuente-Ibáñez de Mendoza I; Warnakulasuriya S
Oral Dis; 2021 Nov; 27(8):1881-1895. PubMed ID: 33606345
[TBL] [Abstract][Full Text] [Related]
16. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity.
Veglia F; Sanseviero E; Gabrilovich DI
Nat Rev Immunol; 2021 Aug; 21(8):485-498. PubMed ID: 33526920
[TBL] [Abstract][Full Text] [Related]
17. Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation.
Xiao Y; Cong M; Li J; He D; Wu Q; Tian P; Wang Y; Yang S; Liang C; Liang Y; Wen J; Liu Y; Luo W; Lv X; He Y; Cheng DD; Zhou T; Zhao W; Zhang P; Zhang X; Xiao Y; Qian Y; Wang H; Gao Q; Yang QC; Yang Q; Hu G
Cancer Cell; 2021 Mar; 39(3):423-437.e7. PubMed ID: 33450198
[TBL] [Abstract][Full Text] [Related]
18. Spatiotemporal analysis of human intestinal development at single-cell resolution.
Fawkner-Corbett D; Antanaviciute A; Parikh K; Jagielowicz M; Gerós AS; Gupta T; Ashley N; Khamis D; Fowler D; Morrissey E; Cunningham C; Johnson PRV; Koohy H; Simmons A
Cell; 2021 Feb; 184(3):810-826.e23. PubMed ID: 33406409
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Associated Macrophages in Tumor Immunity.
Pan Y; Yu Y; Wang X; Zhang T
Front Immunol; 2020; 11():583084. PubMed ID: 33365025
[TBL] [Abstract][Full Text] [Related]
20. IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy.
Weber R; Groth C; Lasser S; Arkhypov I; Petrova V; Altevogt P; Utikal J; Umansky V
Cell Immunol; 2021 Jan; 359():104254. PubMed ID: 33296753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
